Education
About Us
Working with TipRanks
Follow Us
Lee Tien-Li Insider Profile
4 Followers
Lee Tien-Li, Director at Scilex Holding Company, holds ― shares in Scilex Holding Company (Ticker: SCLX), holds 3.02M shares in Aardvark Therapeutics, Inc. (Ticker: AARD). Most recently, Lee Tien-Li ― shares of Scilex Holding Company on ― for an estimated value of ―.
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+50.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Lee Tien-Li holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 12, 2025 - Today
Return:+87.10%
The most profitable trade made by Lee Tien-Li
Lee Tien-Li's Trading History
Scilex Holding Company
―
Director
―
―
Aardvark Therapeutics, Inc.
Sep 16, 2025
CEO, Director, Ten Percent Owner
Informative Buy
96.61K
$52.53M
List of latest transactions for each holding click on a transaction to see Lee Tien-Li's performance on stock
You May Also Like
Lee Tien-Li insider profile FAQ
What is the percentage of profitable transactions made by Lee Tien-Li?
The percentage of profitable transactions made by Lee Tien-Li is 100%.
What is the average return per transaction made by Lee Tien-Li?
The average return per transaction made by Lee Tien-Li is 50.50%.
What stocks does Lee Tien-Li hold?
Lee Tien-Li holds: SCLX, AARD stocks.
What was Lee Tien-Li’s latest transaction?
Lee Tien-Li latest transaction was an Uninformative Buy of ―.
What was Lee Tien-Li's most profitable transaction?
Lee Tien-Li’s most profitable transaction was an Informative Buy of AARD stock on September 12, 2025. The return on the trade was 87.10%.
What is Lee Tien-Li's role in Scilex Holding Company?
Lee Tien-Li's role in Scilex Holding Company is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.